Full Description
50 Studies Every Endocrinologist Should Know assembles landmark, evidence-based studies in classic endocrinology to guide readers towards solving thorny endocrine problems. Featuring a diverse range of study types--including RCTs, multicenter trials, observational studies, and meta-analyses--this volume addresses the core issues faced by endocrinologists in clinical practice. Each chapter provides a concise summary of key studies, highlighting results, limitations, and practical implications. The chapters conclude with a list of major take-home points, which collectively form a foundation of Endocrine Principles that can be applied to real-word patient problems.
As with all books in the "50 Studies" series, each study was selected using an objective selection criterion that included citations per year, high levels of evidence, clinical studies and trials, and a 3-stage Delphi review by international experts in the field. It is an indispensable reference for fellows, physicians, nurse practitioners, and any primary providers with an interest in endocrinology, as well as those taking both the endocrinology board exam and the Endocrinology, Diabetes, & Metabolism certification exam.
Contents
SECTION 1: Conditions caused by Thyroid Damage
Chapter 1: Screening for Thyroid Disease in Early Pregnancy and in Pre-Pregnancy
Chapter 2: Subclinical Hypothyroidism
Chapter 3: Management of Thyroxine in Non-Ablated Patients with Hypothyroidism
Chapter 4: Optimal Thyroid Replacement for the Athyreotic Patient
SECTION 2: Conditions Causing Thyroid Overactivity
Chapter 5: Antithyroid Drugs vs. Ablation in Community Treatment for Graves>' Disease
Chapter 6: Optimum Use of Antithyroid Drugs in Hyperthyroidism
Chapter 7: Risks of I-131 Treatment of Hyperthyroidism
Chapter 8: Hyperthyroidism caused by Amiodarone (AIT)
SECTION 3: Focal and Structural Thyroid Disease
Chapter 9: Selection of Thyroid Nodules to be Biopsied
Chapter 10: Selection of Patients over 45 for Thyroid Biopsy
Chapter 11: Molecular Genomic Testing (MGT) for Indeterminate Thyroid Nodules
Chapter 12: Complication Rate(s) from Thyroidectomy
Chapter 13: Ablation Techniques for Benign or Hot Nodules
Chapter 14: Microscopic Papillary Thyroid Carcinoma (mPTC) and Active Surveillance (AS)
Chapter 15: Optimal Work-up and Surgery for a small, non-metastatic DTCA
Chapter 16: I-131 Treatment for DTCA
SECTION 4: Parathyroid Diseases
Chapter 17: Active Surveillance and/or Medical Therapy for Hyperparathyroidism in Older Patients
Chapter 18: Preoperative Localization of Sporadic Primary Hyperparathyroidism
Chapter 19: Quality of Life after Surgery for Mild/Moderate Sporadic Primary Hyperparathyroidism
Chapter 20: Secondary Hyperparathyroidism, Idiopathic Hypercalciuria, and Bone Density
Chapter 21: Recurrent and/or Persistent Primary Hyperparathyroidism
SECTION 5: Metabolic Bone Disease
Chapter 22: Calcium and Vitamin D Effects on Bone Mass
Chapter 23: Fracture Prevention in Patients with Low Bone Mass
Chapter 24: Pretreatment Evaluation for Osteoporosis
Chapter 25: Evaluation of Fracture Risk in Osteoporosis
Chapter 26: Osteoporosis and Hip Fracture Prevention
Chapter 27: Alendronate and Fracture Risk Reduction
Chapter 28: Hip Fracture in the Elderly with Very Low Bone Density
Chapter 29: Anabolic Agent(s) for Osteoporosis
Chapter 30: Glucocorticoid Osteoporosis
Chapter 31: Osteoporosis in Men
SECTION 6: Adrenal Conditions
Chapter 32: The Importance of Recognizing Hyperaldosteronism
Chapter 33: Effectiveness of Treatment of Hyperaldosteronism
Chapter 34: Screening for Adrenal Insufficiency
Chapter 35: Adrenal Incidentalomas
Chapter 36: Opioid-Induced Endocrine Deficiencies
Chapter 37: Adrenal Insufficiency from Corticosteroid Treatment
Chapter 38: Optimal Testing for ACTH-Dependent Hypercortisolism
SECTION 7: Pituitary Tumors / Hypercortisolism
Chapter 39: Duration of Medical Treatment of Intrasellar Prolactinomas
Chapter 40: Acromegaly Treatment-Surgery, Medication, or What?
Chapter 41: Primary Treatment of Pituitary Hypercortisolism
Chapter 42: Treatment of Recurrent or Persistent Hypercortisolism
SECTION 8: Conditions Caused by Testosterone Deficiency
Chapter 43: Risks of Testosterone Treatment in Older Men
Chapter 44: Male Obesity Secondary Hypogonadism (MOSH)
SECTION 9: Conditions Related to Estrogen Deficiency
Chapter 45: Estrogen Treatment and Cardiovascular Health
Chapter 46: Estrogen Treatment and Skeletal Health
Chapter 47: Estrogen + Progestin vs. Estrogen Alone, and Neoplasia
SECTION 10: Polycystic Ovary Syndrome
Chapter 48: Optimal Differential Diagnosis of PCOS
Chapter 49: Optimal Treatment of Hirsutism in PCOS
Chapter 50: Treatment of Subfertility in PCOS
